Antibiotic Therapy Practices for Ventilator-Associated Pneumonia (PETUNIA)
NCT06243094 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1060
Last updated 2024-03-15
Summary
The French Society of Intensive Care conducts a comprehensive assessment of current antibiotic therapy practices in critically ill patients suspected of Ventilator-Associated Pneumonia (VAP).
Conditions
- Ventilator Associated Pneumonia
Interventions
- DRUG
-
Antibiotic
All antibiotic therapy characteristics are monitored.
Sponsors & Collaborators
-
French Society for Intensive Care
lead OTHER
Principal Investigators
-
Anahita Rouzé, MD · French Intensive Care Society
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-12
- Primary Completion
- 2025-03-12
- Completion
- 2025-03-12
Countries
- France
Study Locations
More Related Trials
-
Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected Patients
NCT04344509 ·Status: UNKNOWN
-
Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients
NCT00543894 ·Status: COMPLETED
-
Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
NCT07052604 ·Status: RECRUITING
-
Prevention of Ventilator Associated Pneumonia With Toothbrushing in Oral Care of Critically Ill Mechanically Ventilated Patients
NCT02400294 ·Status: COMPLETED
-
Defining Antibiotic Treatment Duration for Ventilator - Associated Lung Infection
NCT03382548 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Antibiotic Rotation in the ICU on the Prevalence of Antibiotic Resistant Gram-negative Colonisation
NCT01293071 ·Status: COMPLETED ·Phase: PHASE4
-
Bacterial Transmission Dynamics Study
NCT02401204 ·Status: COMPLETED
-
Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU
NCT02413242 ·Status: COMPLETED
-
Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria
NCT03752476 ·Status: UNKNOWN
-
Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens
NCT06554327 ·Status: RECRUITING ·Phase: NA
-
Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia (iDIAPASON)
NCT02634411 ·Status: COMPLETED ·Phase: NA
-
Compliance With AntibIotic TherapY Guidelines in French PICUs
NCT04642560 ·Status: COMPLETED
-
Delayed Antibiotic Therapy in Non-severe Ventilator Acquired Pneumonia (VAP)
NCT05205525 ·Status: COMPLETED
-
Early Antibiotics After Aspiration in ICU Patients
NCT05079620 ·Status: TERMINATED ·Phase: PHASE4
-
Prospective Randomized Controlled Multicenter Trial of 4 Antiseptic Strategies for Prevention of Catheter Infection in Intensive Care Unit for Adults Patients
NCT01629550 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of the Implementation of a Clinical Pharmacy Bundle on Intensive Care Unit Patient Outcomes and Cost Expenditures
NCT02924844 ·Status: COMPLETED
-
Predictive Factors of Good Pulmonary Penetration of Antibiotics : AntiBiotics Dosage in Broncho-Alveolar Lavage
NCT03927079 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit
NCT01878643 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
DetermInants of Antimicrobial Use aNd De-escalAtion in Critical Care
NCT03664245 ·Status: UNKNOWN
-
Prevention of pneumonIA in Nursing hOme
NCT04121182 ·Status: COMPLETED ·Phase: NA
-
Direct E-test on Bronchoalveolar Lavage From Patients With Ventilator-acquired Pneumonia
NCT01042353 ·Status: COMPLETED ·Phase: PHASE4
-
7-days Versus 14 Days of Antibiotics Therapy for Ventilator Associated Pneumonia
NCT03477292 ·Status: COMPLETED ·Phase: NA
-
Prognosis and Virulence Determination of Capsule and Endotoxin During Klebsiella Spp. Ventilator-associated Pneumonias
NCT05450796 ·Status: UNKNOWN
-
Inhaled Polymyxin E to Prevent VAP
NCT06819462 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Cohort Study on Anti-microbial Stewardship in PICU
NCT05862688 ·Status: NOT_YET_RECRUITING